93M1 Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low debt relative to equity gives MPH substantial financial flexibility and reduces exposure to interest costs and refinancing pressure. This conservative funding profile can help the holding company withstand portfolio volatility and preserve capacity for future investments or shareholder distributions.
Return To Sustained ProfitabilityA return to positive earnings since 2022, followed by solid profitability in 2025, indicates that the portfolio can generate accounting profits after earlier losses. Maintaining positive margins supports reinvestment, strengthens resilience, and provides a more durable earnings base than the 2020–2021 period.
Healthcare And Life Sciences FocusA defined focus on healthcare and life sciences gives MPH a consistent investment mandate rather than exposure to an unrelated collection of industries. These sectors provide the company with a durable strategic area for selecting, financing, and overseeing portfolio interests over time.
Bears Say
Highly Erratic RevenueLarge swings in revenue make it difficult to establish a dependable top-line growth trend or forecast recurring earnings. The instability raises questions about the durability and quality of reported income, which can make portfolio performance and future capital allocation less predictable.
Volatile Cash GenerationRepeated weakness in operating and free cash flow shows that reported profitability has not consistently converted into internally generated cash. Limited cash conversion reduces self-funding capacity, may constrain distributions or new investments, and lowers confidence in the sustainability of earnings.
Declining Equity BaseA decline in equity during the latest period indicates pressure on the capital base despite the company’s low leverage. If this trend persists, it could reduce the resources supporting portfolio investments and weaken financial flexibility, even without a material increase in debt.
93M1 FAQ
What was MPH Health Care AG’s price range in the past 12 months?
Currently, no data Available
What is MPH Health Care AG’s market cap?
MPH Health Care AG’s market cap is CHF103.55M.
When is MPH Health Care AG’s upcoming earnings report date?
MPH Health Care AG’s upcoming earnings report date is Sep 16, 2026 which is in 8 days.
How were MPH Health Care AG’s earnings last quarter?
MPH Health Care AG released its earnings results on May 27, 2026. The company reported $9.547 earnings per share for the quarter.
Is MPH Health Care AG overvalued?
According to Wall Street analysts MPH Health Care AG’s price is currently Undervalued.
Does MPH Health Care AG pay dividends?
MPH Health Care AG does not currently pay dividends.
What is MPH Health Care AG’s EPS estimate?
MPH Health Care AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MPH Health Care AG have?
Currently, no data Available
What happened to MPH Health Care AG’s price movement after its last earnings report?
MPH Health Care AG reported an EPS of $9.547 in its last earnings report. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of MPH Health Care AG?
Currently, no hedge funds are holding shares in CH:93M1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
MPH Health Care AG Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
79.77%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-11.33%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
MPH Health Care AG
MPH Health Care AG is a German-based investment firm with a primary focus on the healthcare sector. The company's portfolio includes the production and distribution of medicinal products designed to treat serious illnesses like cancer, HIV, and various other chronic conditions. Beyond pharmaceuticals, it also delivers medical aesthetic treatments, develops and markets a diverse array of pharmaceutical and medical items, and furnishes related services and specialized medical devices for use in aesthetic surgery and cosmetic dermatology. Furthermore, its operations extend to supplying cytostatic solutions and involvement in real estate ventures. Established in Berlin in 2008, the company adopted its current name, MPH Health Care AG, in 2017, having previously been known as MPH Mittelständische Pharma Holding AG. It functions as a subsidiary of Magnum AG.